Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23123)

• Formulation Name: Dacarbazine 200mg/vial injectable
• Company: Hikma Pharmaceuticals Usa

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Dacarbazine	(DMNPZL4)	Adenocarcinoma	2D40	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Kyselina citronova	(E00014)	311	Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent